Daiichi Sankyo

Pharma

Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia

CARsgen won the world's first approval for a solid tumor CAR-T. Pfizer and Innovent's $10 billion deal was formed within five months. Plus more China deals.

Angus Liu Jun 26, 2026 8:51am

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm

Gilead's Trodelvy stumbles in first-line NSCLC

Jun 9, 2026 11:14am

AZ, Daiichi's Datroway approved in first-line TNBC

May 22, 2026 11:32am

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

May 22, 2026 8:53am

In endometrial cancer, Merck and Kelun score with sac-TMT

May 18, 2026 11:21am